Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Cho, H., Gonzales-Wartz, K. K., Huang, D., Yuan M., Peterson, M., Liang, J., Beutler, N., Torres, J. L., Cong, Y., Postnikova, E., Bangaru, S., Talana, C. A., Shi, W., Yang, E. S., Zhang, Y., Leung, K., Wang, L., Peng, L., Skinner, J., Li, S., Wu, N. C., Liu, H., Dacon, C., Moyer,T., Cohen, M., Zhao, M., Lee, F. E., Weinberg, R. S.,Douagi, I., Gross, R., Schmaljohn, C., Pegu, A., Mascola, J. R., Holbrook, M., Nemazee, D., Rogers, T. F.,Ward, A. B., Wilson, I. A., Crompton, P. D., Tan, J.  Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.  Sci. Transl. Med. 2021.  doi: 10.1126/scitranslmed.abj5413